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SUMMARY 
During spinal cord development the combination of secreted signaling proteins 
and transcription factors provide information for each neural type differentiation. 
Studies using embryonic stem cells show that trimethylation of lysine 27 of histone 
H3 (H3K27me3) contributes to repression of many genes key for neural 
development. However, it remains unclear how H3K27me3-mediated mechanisms 
control neurogenesis in developing spinal cord. Here we demonstrate that 
H3K27me3 controls dorsal interneuron generation by regulation of BMP activity. 
Our study indicates that Noggin expression, a BMP extracellular inhibitor, is 
repressed by H3K27me3. Moreover, we show that Noggin expression is induced by 
BMP pathway signaling, generating a negative feedback regulatory loop. In 
response to BMP pathway activation, JMJD3 histone demethylase interacts with 
Smad1/Smad4 complex to demethylate and activate Noggin promoter. Together 
our data reveal how BMP signaling pathway restricts its own activity in developing 
spinal cord by modulating H3K27me3 levels at Noggin promoter. 
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INTRODUCTION 
 During embryogenesis, multipotent neuroepithelial precursor cells originate 
specialized neurons and different glial cell types (Gage, 2000; Roegiers and Jan, 2004; 
Temple, 2001). Whether a precursor cell either self-renews or differentiates is regulated 
by interactions between transcription factors and secreted signaling proteins that 
provide positional information (Jessell, 2000; Zhu and Scott, 2004). Bone 
Morphogenetic Proteins (BMP) are some of these extracellular proteins. In developing 
spinal cord, BMPs regulate several processes such as differentiation to dorsal 
interneurons (Liu and Niswander, 2005; Timmer et al., 2002). These differentiation 
processes require nuclear reorganization and general changes in gene expression, 
indicating that epigenetic changes may be involved (Buszczak and Spradling, 2006; 
Hsieh and Gage, 2005; Kondo, 2006). One of the best-illustrated epigenetic effects on 
regulation of pluripotency and differentiation induction is the effect mediated by 
Polycomb repressive complexes (PRC) (Ringrose and Paro, 2007). The hallmark for 
Polycomb-mediated repression is the methylation of lysine 27 of histone H3 
(H3K27me3) (Czermin et al., 2002; Muller et al., 2002). Enhancer of Zeste Homolog 2 
(EZH2), a subunit of the PRC2 complex, is responsible for histone methyltransferase 
activity (Cao et al., 2002; Czermin et al., 2002; Kuzmichev et al., 2002). This mark is 
recognized by the chromodomain of Polycomb protein that forms part of the PRC1 
(Cao et al., 2002). The recruitment of PRC1 leads to final transcriptional repression that 
is reversible by JMJD3 and UTX demethylase activity (Agger et al., 2007; De Santa et 
al., 2007; Lan et al., 2007; Lee et al., 2007). The balance between methyltransferase and 
demethylase activity gives a dynamic character which is reflected by the fact that many 
key developmental promoters are often marked by H3K27me3 (Boyer et al., 2006; 
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Bracken et al., 2006; Lee et al., 2006; Pan et al., 2007). In addition to H3K27me3, an 
active modification, H3K4me, is often found at these promoters (Bernstein et al., 2006; 
Mikkelsen et al., 2007; Pan et al., 2007; Zhao et al., 2007). It is believed that the 
presence of both activating and repressive chromatin marks keeps these developmental 
regulators poised for rapid resolution after the appropriate stimulus is received 
(Bernstein et al., 2006). 
 Many models have been used to examine epigenetic changes that take place 
during cell differentiation and, in particular, to analyze the role of Polycomb complexes 
using embryonic stem cells (ESC) (Boyer et al., 2006; Bracken et al., 2006; Lee et al., 
2006; Pietersen and van Lohuizen, 2008). However, these systems generally do not 
progress toward a specific terminal cell type as it occurs in vivo. In this paper we take 
advantage of an in vivo model for neurogenesis, the chick embryo neural tube, to 
analyze the role of H3K27me3 during nervous system development.  
  Here we report an H3K27me3-mediated mechanism to edge the boundaries of 
BMP activity during spinal cord development. We show that expression of Noggin, an 
extracellular inhibitor of BMPs, is regulated by H3K27me3. As a consequence, a 
reduction of H3K27me3 disturbs BMP-regulated dorsal spinal cord development. 
Moreover, we show that H3K27me3-mediated Noggin repression is sensitive to 
changes in BMP activity. Hyperactivation of BMP signaling pathway induces JMJD3 
interaction with Smad1/Smad4 and their recruitment to Noggin promoter for 
H3K27me3 demethylation that triggers Noggin expression. Our results reveal an 
essential role of H3K27me3 in the negative feedback regulation of BMP signaling that 
guarantees proper neurogenesis in developing chick neural tube. 
 
MATERIALS AND METHODS 
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Plasmids and recombinant proteins  
Human EZH2 and its deleted form lacking SET domain (aminoacid 622-707) were 
cloned from pCDNA3 (Caretti et al., 2004) into pCIG vector (Megason and McMahon, 
2002), upstream of an internal ribosomal entry site (IRES) and three nuclear localization 
sequences-tagged EGFP. Human Myc-JMJD3 and Myc-JMJD3DN (H1390A truncated 
JMJD3) (Xiang et al., 2007) were cloned into pCIG. Mouse BMP4/7, chick Shh 
(Roberts et al., 1998) and human FlagSmad1 (Liu et al., 1996) were also cloned into 
pCIG. Mouse Wnt1, chick Noggin and human HaSmad4 are described elsewhere 
(Alvarez-Medina et al., 2008; Garcia-Campmany and Marti, 2007). DNA sequences for 
chick Noggin shRNA and a random shRNA (shRNA C-) were cloned into pSHIN 
vector (Kojima et al., 2004). Noggin shRNA target sequence: 5’gtggctctggtcccagacc3’. 
Random sequence: 5’gctccacatcagtccttcc3’ 
Chick in ovo electroporation 
Eggs from White-Leghorn chickens were incubated at 38.5ºC and 70% humidity. 
Embryos were staged following Hamburger and Hamilton (HH) (Hamburger and 
Hamilton, 1992). Chick embryos were electroporated with purified plasmid DNA at 
0.25-3 µg/µl in H2O with 50 ng/ml of Fast Green. Plasmid DNA was injected into the 
lumen of HH10 or HH16 neural tubes, electrodes were placed at both sides of the neural 
tube and embryos were electroporated by an IntracelDual Pulse (TSS-100) 
electroporator delivering five 50 ms square pulses of 20-25 V.  
Antibodies 
Antibodies used were: anti-BrdU, anti-Pax7, anti-ISL1/2 (DSHB), anti-neural b-Tubulin 
III (Tuj1), anti-Pax6 (Covance), anti-LHX2/9 (from TM Jessell), anti-trimethylH3K27, 
anti-acetylH3 (K9 and K14), anti-acetylH4 (K12), anti-di/trimethylH3K4, anti-
trimethylH4K20, anti-phosphoH3S10 (Upstate Biotechnology), anti-EZH1 (kindly 
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provided by Dr. Reinberg), anti-trimethylH3K9 (Abcam, UK), anti-HA (Sigma H6908), 
anti-Flag (Sigma M2), anti-phosphoSmad1/5/8 (Cell signaling), anti-myc ChIP Grade 
(Abcam) and anti-myc (from Dr. S. Pons). 
Indirect immunofluorescence 
The collected embryos’ brachial regions were fixed for 2h at 4ºC in 4% 
paraformaldehyde, rinsed, sunk in PBS 30% sucrose solution and embedded in OCT for 
sectioning in LEICA cryostat (CM 1900). Sections were blocked at room temperature 
for 1h in 1% bovine serum albumin (in PBS with 0.1% TritonX) before overnight (O/N) 
incubation at 4ºC with primary antibodies. Finally, sections were incubated for 2h at 
room temperature with Alexa-conjugated goat secondary IgG antibodies (Jackson 
Immuno Research Inc.) and 0.1 ng/µl DAPI (Sigma). Images were captured by Leica 
SP5 confocal microscope using LAS-AF software. Fluorescence intensity was 
quantified using Leica LAS-AF software.  
Histone extraction and Immunoblotting 
HH14 and HH25 wild-type (WT) embryos were collected and neural tubes were 
dissected out. For histone acid extraction, neural tubes were incubated for 30 min at 4ºC 
in lysis buffer (Hepes/kOH 10 nM, MgCl2 1.5 mM, KCl 10 mM, DTT 0.5 mM, PMSF 
1.5 mM, TSA 0.33 µM, HCl 0.2 N). After centrifugation for 10 min at 13,400 rpm, 
supernatant was collected and dialysis was done, with acetic acid 0.1 M and miliQ H20, 
using slide-A-lyzer mini dialysis units (Pierce). Histone concentration was measured 
with Bradford protein assay reagent and 10 µg of proteins were separated in SDS-
PAGE gel. Immunoblotting was performed with standard procedures and visualized by 
ECL kit (Amersham).  
BrdU incorporation 
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0.5 µg/ml bromodeoxyuridine (BrdU) was injected into the chick embryo neural tube 
lumen  30 min before fixation. BrdU was detected on sections by treatment with HCl2 
N for 30 min, NaBorate 0.1 M (pH 8.5) and incubation with anti-BrdU antibody.  
In situ hybridization (ISH) 
Embryos were fixed overnight at 4ºC in 4% paraformaldehyde, rinsed and processed for 
whole-mount RNA ISH , following standard procedures using ESTbank probes for 
chick EZH2, JMJD3, Hes5, NeuroD, NeuroM, Noggin, ID1 and ID3. After 
hybridization, embryos were post-fixed in paraformaldehyde 4% for 2h, embedded in 
sucrose 10%, agarose 5% solution and sectioned in a Leica vibratome (VT 1000S).  
Fluorescent associated cell sorting (FACS) 
Electroporated embryos were dissected out and trypsinized for 5-10 min in Trypsin-
EDTA 0.5% (Sigma). Trypsinization was stopped with  20% horse serum in PBS-0.1% 
glucose solution. GFP+ cells from cell suspension were sorted by flow cytometry using 
a MoFlo flow cytometer (DakoCytomation, Fort Collins, CO).  
Cell cycle analysis 
Trypsinized cell suspension from electroporated neural tubes was treated 2h at room 
temperature with 10 µg/ml Hoescht33342. Hoescht and GFP fluorescence were 
determined by flow cytometry using a MoFlo flow cytometer (DakoCytomation, Fort 
Collins, CO). DNA content analysis (Ploidy analysis) was done using Multicycle 
software (Phoenix Flow Systems, San Diego, CA). 
Microarrays analysis 
Fifteen chick embryo neural tubes were electroporated with empty vector or 
EZH2DSET for each replicates. RNA-s from 100,000 FACS-purified GFP+ cells of 
each replicate were supplied to IRB's Affymetrix Facility for quality control, 
quantification, reverse transcription, labeling and hybridization onto Affymetrix 
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Chicken GeneChip. Results in CEL files were provided to the Bioinformatics and Data 
Analysis service of UB-SCT, for analysis of data quality, normalization with the RMA 
algorithm and selection of differentially expressed genes (absolute fold change >1.5 in 
both replicates). 
mRNA extraction and quantitative PCR (qPCR) 
mRNA from FACS-separated cells or from dissected neural tubes was extracted by 
TRIZOL (Invitrogen) protocol with 2 µl of pellet paint co-precipitant (Novagene). 
Reverse transcription was performed with Transcriptor kit (Roche), following the 
manufacturer’s procedure. qPCR was performed with Sybergreen (Roche) in LC480 
Lightcycler (Roche). GapdH was used for normalization. Primer sequences:  Noggin 
FW5’gctacagtaaaaggtcttgctc3’; RW5’cctcaggatcgttaaatgcac3’; Hes5 
FW5’taaaccataactcaagctgtgtag3’; RW5’gcatacatatcctgaacctcac3’; NeuD 
FW5’actacttgttacctttcccg3’; RW5’atggtttaaaataggaaatccacg3’; Id1 
FW5’tgaagggctgctactcg3’; RW5’aggtcccagatgtagtcg3’; Id3 
FW5’cgactgctactccaaattgc3’; RW5’gaagatataatcgatgacgtgctg3’. 
Chromatin immunoprecipitation (ChIP)  
For histone ChIPs 300,000-400,000 cells separated by FACS or 2-3 dissected neural 
tubes, were used. ChIPs were performed essentially as described elsewhere (Attema et 
al., 2007). Cells were treated with formaldehyde 1% at room temperature for 10 min. 
The reaction was stopped  with 125 mM glycine. Cells were washed once in ice-cold 
PBS with protease inhibitors and lysed with 50 µl lysis buffer [SDS 1%, EDTA 10 mM, 
Tris 50 mM (pH 8), protease inhibitors 1 µg/ml, PMSF 1 mM], incubated 5 min on ice 
and diluted with 150 µl PBS before 10 min sonication in biorruptor (Novagene) (High 
power, 30 sec ON, 1 min OFF). 200-500bp chromatin fragments containing supernatant 
was precleared with 8 µl of proteinA agarose/ssDNA beads (Upstate 16-157) for 30 min 
  Akizu et al. 
 9 
at 4ºC under rotation. Supernatant was recovered by centrifugation and input was 
separated. The rest of the chromatin was diluted with IP buffer [Triton X-100 1%, 
EDTA 2 mM, NaCl 150 mM, Tris 20 mM (pH 8) and protease inhibitors] and divided 
into three eppendorfs. 2 µg of antibodies or IgG were added O/N incubation at 4ºC 
under rotation. Antibody:protein:DNA complexes were then collected with 10 µl of 
proteinA agarose/ssDNA beads for 1h. The beads were washed with buffers I [SDS 
0.1%, Triton X-100 1%, EDTA 2 mM, Tris-HCl 20 mM (pH 8), NaCl 150 mM], II 
[SDS 0.1%,  Triton X-100 1%,  EDTA 2mM, Tris-HCl 20 mM (pH 8), NaCl 500 mM], 
III [LiCl 0.25 M, NP40 1%, NaDOC 1%, EDTA 1mM, Tris-HCl 10 mM (pH 8)], and 
three times with Tris-EDTA. Washed pellets were eluted with 400 µl of SDS 1%, 
NaHCO3 0.1 M solution and de-crosslinked O/N at 65ºC. DNA was recovered by using 
phenol chloroform extraction and ethanol precipitation.  
For non histone proteins ChIPs were performed as described above with some 
modifications: 400,000-500,000 cells separated by FACS or 20-25 dissected 
electroporated side of neural tubes, were fixed at room temperature 45 min with DSG 2 
mM (Sigma) and 20 min with formaldehyde 1%. Cells were lysed with 1.1 ml lysis 
buffer [SDS 0.1%, EDTA 1 mM, Tris 20 mM (pH 8), Triton X-100 1%, NaCl 150 mM, 
protease inhibitors 1 µg/ml, PMSF 1 mM]. After immunoprecipitation beads were 
washed with buffers I (SDS 0.1%, NaDOC 0.1%, Triton X-100 1%, EDTA 1 mM, 
HEPES 20 mM, NaCl 150 mM), II (SDS 0.1%, NaDOC 0.1%, Triton X-100 1%, 
EDTA 1 mM, HEPES 20 mM, NaCl 500 mM), III (LiCl 250 mM, NP40 0.5%, NaDOC 
0.5%, EDTA 1mM, HEPES 20 mM), and IV (EDTA 10 mM, HEPES 200 mM).  
DNA was analyzed by qPCR with Sybergreen (Roche) in LC480 (Roche). Primer 
sequences are: Noggin(-2000) FW5’cttgcgatgctttttgtgac3’, 
RW5’cgtggagcagttttacagac3’; Noggin(-1000) FW5’gggtagggtgggttagaaga3’, 
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RW5’ccaaagcctttaaatttcctgc3’; Noggin(+300) FW5’gctacagtaaaaggtcttgctc3’, 
RW5’cctcaggatcgttaaatgcac3’; Hes5(-2000) FW5’tgaaagattggcagaggaaac3’, 
RW5’gtacccatttctcactacagc3’; NeuD(-2000) FW5’ttccgtaatcgtgtgtactcg3’, 
RW5’atttagttaatggaaaagacatcgc3’. 
Cell culture, transfection and Coimmunoprecipitation (CoIP) assay 
Hek293T cells were grown in DMEM with 10% fetal calf serum and 1% 
Penicillin/Streptomycin at 37°C, 5% CO2. Cells were transfected by a standard calcium 
phosphate co-precipitation protocol and harvested 48h after transfection. 
Immunoprecipitations and immunoblot analysis were performed essentially as described 
elsewhere (Valls et al., 2003).. Immunoblotting was performed using standard 
procedures and visualized using ECL kit (Amersham).  
Identification of Smad binding sequences in the Noggin promoter region 
Sequence comparison of the Noggin locus between Human and Chicken was performed 
using the global alignment programme Shuffle-LAGAN (Brudno et al., 2003) and 
visualized with  VISTA visualization tool (Mayor et al., 2000). Smad conserved binding 
sites were found using rVISTA 2.0 searches for Smad matrix from the TRANSFAC 
library. 
Statistical analysis 
Quantitative data were expressed as mean and standard deviation (s.d.). Significant 
differences between groups were tested by Student’s t-test. 
 
RESULTS  
H3K27me3 global levels increase during neural differentiation 
To understand the contribution of histone marks in neural development, we 
examined their distribution throughout early development. We studied the pattern of 
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histone acetylation and methylation in HH14 and HH25 chick embryo neural tubes. 
While in HH14 embryos the neural tube is mainly formed by proliferating neuroblasts 
in HH25 embryos two zones are distinguished: the ventricular zone (VZ) formed by 
proliferating neuroblasts and the mantle zone (MZ) where differentiated neurons reside 
(Fig. 1A). First, we analyzed histone marks along neurogenesis by immunoblotting of 
histones purified from neural tubes. While global histone acetylation and H3K4me2/3 
levels were similar in HH14 and HH25 embryo neural tubes (Supplementary Fig. 1A), 
clear increase in global H3K27me3 was detected from stage HH14 to stage HH25 (Fig. 
1B). This correlates not only with neurogenesis progression but also with enrichment in 
differentiated neurons. Then, we tested whether H3K27me3 levels were higher in 
differentiated neurons than in proliferating neuroblasts. By HH25 embryo neural tubes 
immunostaining we observed that global H3K27me3 levels were 3 times higher in 
differentiated neurons (MZ) than in neuroblasts (VZ) (Fig. 1C). These data indicate that 
global H3K27me3 levels increase along neurogenesis, while differentiated neurons 
accumulate in the neural tube. Similar results were observed for H3K9me3 and for 
H4K20me3 (Supplementary Fig. 1B). 
The observed global H3K27me3 level increase led us to analyze the expression 
of the two mayor enzymes responsible for H3K27me3, EZH2 and JMJD3. Transversal 
sections of HH10 and HH14 embryo ISH show that EZH2 and JMJD3 are ubiquitously 
expressed in the neural tube, although their expression level is higher in the dorsal 
region (Fig. 1D,E). At HH25 neural tubes, EZH2 and JMJD3 are highly expressed in 
VZ while the mRNA levels of both enzymes in MZ are lower. Moreover the VZ 
expression of EZH2 and JMJD3 is higher at dorsal neuroblasts, resulting in a well 
defined dorsal JMJD3 domain and a dorsoventral EZH2 gradient (Fig. 1D,E). The 
EZH2 and JMJD3 expression pattern suggests that H3K27me3 could be more 
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dynamically controlled in VZ neuroblasts, especially at dorsal region. However, it 
doesn’t completely correlate with global H3K27me3 increase during neural 
differentiation. Thus, we analyzed the expression of EZH1, whose histone 
methyltransferase (HMT) activity has been recently described (Margueron et al., 2008; 
Shen et al., 2008). Supplementary Fig. 1C shows that EZH1 expression is higher in 
differentiated neurons than in proliferating neuroblasts at HH30 embryo neural tubes. 
This result suggests that in addition to EZH2 and JMJD3, EZH1 contributes to the  
H3K27me3 levels maintaining at differentiated neurons. 
   
Maintenance of global H3K27me3 is not required for neural differentiation or for 
progenitor proliferation 
Consistent with the observed global H3K27me3 levels increase during neural 
differentiation (Fig. 1B,C) recent evidences demonstrates that PcG proteins and 
H3K27me3 are present at promoters of many genes specific for neurogenesis (Boyer et 
al., 2006; Lee et al., 2006; Pietersen and van Lohuizen, 2008). Therefore, we 
investigated whether a global H3K27me3 increase is required for neurogenesis 
(although this does not necessarily reflect a requirement of H3K27me3 at a particular 
chromatin locus). To address this possibility we reduced global H3K27me3 levels in the 
chick neural tube to next analyze the effects on neural differentiation. In order to reduce 
H3K27me3 levels, chick embryo neural tubes were in ovo electroporated with a 
dominant negative form of EZH2 (EZH2DSET), which lacks the SET domain 
responsible for HMT activity. First, we tested the ability of EZH2DSET to block 
endogenous EZH activity. Fig. 2A shows that EZH2DSET over-expression (GFP+ 
cells) reduces by 70% endogenous H3K27me3 levels 24h post-electroporation (PE). 
H3K27me3 is maintained at low levels for 48h, but it starts to recover 72h-PE 
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(Supplementary Fig. 2A). EZH2 over-expression caused no change in global 
H3K27me3 levels (Fig. 2A). Similarly, no changes in global H3K9me3 or H3K4me3 
levels were detected after EZH2DSET over-expression (Supplementary Fig. 2B,C). 
Once global H3K27me3 levels were reduced in chick neural tube, we examined its role 
in neural differentiation by analyzing the expression of NeuroD and NeuroM, proneural 
genes expressed in differentiating neurons and previously identified as H3K27me3 
targets in ESC (Boyer et al., 2006; Lee et al., 2006). To this end, EZH2DSET, EZH2 or 
the empty vector were electroporated in HH10 embryo neural tubes, when the neural 
tube is mainly formed by proliferating neuroblasts. No changes in the expression levels 
of NeuroD and NeuroM differentiation markers were detected after H3K27me3 
reduction (Supplementary Fig. 3A). To confirm these results, we checked the pan-
neural differentiation marker Tuj. Embryos transfected with EZH2DSET and stained for 
Tuj does not show changes in the number of differentiated cells neither at 48h nor at 
72h-PE (Fig. 2B and Supplementary Fig. 4A). These results indicate that global 
H3K27me3 maintenance is not essential to neural differentiation; the observed global 
H3K27me3 increase during neurogenesis might be a consequence of the differentiation 
process itself, in which extensive structural changes in chromatin are known to take 
place over all the genome (Keenen and de la Serna, 2009). In line with this hypothesis, 
other heterochromatin marks, such as H3K9me3 and H4K20me3, also increase during 
neurogenesis (Supplementary Fig. 1B). 
The high EZH2 and JMJD3 expression at the VZ suggests that a dynamic 
control of H3K27me3 might be important in neuroblast proliferation. Moreover, EZH2 
and H3K27me3 regulate  several proliferating processes (Agger et al., 2009; Bracken et 
al., 2003; Ezhkova et al., 2009; Varambally et al., 2002). Then, we analyzed the 
function of H3K27me3 in the maintenance of the proliferating neuroblast population. 
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To this end, EZH2DSET, EZH2 or the empty vector were electroporated in HH10 
embryo neural tubes and the effect on neuroblast proliferation and cell cycle 
progression was analyzed. Immunostaining using H3S10p antibody shows that 
electroporated and control sides of the neural tubes have the same number of mitotic 
cells  (Supplementary Fig. 3B). We also evaluated neural tube cells entry into S-phase 
of the cell cycle: when electroporated embryos were pulse-labeled with BrdU, no 
differences were observed between EZH2DSET, EZH2 or empty vector 
electroporations neither at 24h nor at 72h-PE (Fig. 2C and Supplementary Fig. 4B). 
Finally, by GFP+ DNA content analysis, no changes on cell cycle phase distribution 
were observed after global H3K27me3 decrease (Supplementary Fig. 3C and 
Supplementary Fig. 4C). Taken together, these findings suggest that global H3K27me3 
levelmaintenance is not essential to neuroblast proliferation. 
 
H3K27me3 regulates BMP activity  
Next, we examined whether the observed dorsoventral expression gradient of 
EZH2 and JMJD3 (Fig. 1D,E) has any physiological significance in the neural tube 
dorsoventral pattern formation. We analyzed the development of dorsal neural 
populations by immunostaining of Lhx2/9 and Isl1/2 dorsal interneuron markers, after 
H3K27me3 reduction (by EZH2DSET over-expression). Lhx2/9 and Isl1/2 positive 
dorsal interneuron populations decrease in EZH2DSET electroporated side of the neural 
tubes (Fig. 3A). It is well established that BMP pathway is the main factor responsible 
for dorsal patterning of the neural tube (Liu and Niswander, 2005; Timmer et al., 2002). 
Then, we examined whether low levels of H3K27me3 affect BMP activity. To this end, 
we activated the BMP pathway by in ovo electroporation of BMP expression vector in 
the presence or absence of EZH2DSET. The expression pattern of Pax6/7 genes, known 
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to be regulated by BMP activity (Liu and Niswander, 2005), was analyzed by 
immunostaining. Fig. 3B shows that BMP activity leads to a ventral expansion of 
Pax6/7 domains that is counteracted by H3K27me3 reduction after EZH2DSET over-
expression. This result indicates that H3K27me3 is required to maintain proper BMP 
activity in the developing spinal cord.  
 
BMP activity is regulated by Noggin induction via H3K27 demethylation 
To understand how H3K27me3 regulates BMP activity, we performed a micro-
array analysis comparing GFP+ cells purified by FACS from EZH2DSET or empty 
vector electroporated neural tubes (Fig. 4A left panel). Differentially upregulated genes 
after H3K27me3 removal (by EZH2DSET electroporation) were analyzed by Gene 
Ontology (GO). 22 upregulated genes were associated with seven GO biological 
process terms related to nervous system development (Fig. 4A right panel). 
Interestingly, we found among them Noggin, a known BMP inhibitor (Zimmerman et 
al., 1996). As confirmed by qPCR, Noggin is upregulated (1.9±0.6-fold) in 
EZH2DSET-transfected neural tube cells (Fig. 4B), suggesting that Noggin 
upregulation could be responsible for the phenotype described above. 
In order to examine whether changes in Noggin expression are directly 
associated with H3K27me3 levels, HH16-18 embryo neural tubes were dissected out 
and H3K27me3 ChIP analysis were performed. In addition to Noggin, NeuroD and 
Hes5 promoters, which are not transcriptionally affected by H3K27me3 reduction (Fig. 
4B), were also analyzed. Hes5 was used as a negative control of ChIP analysis, as it is 
highly expressed in neural tubes (ISH in Fig. 4C) and, thus, it is expected not to be 
enriched in H3K27me3. NeuroD, a known H3K27me3 target in ESC (Boyer et al., 
2006; Lee et al., 2006) and repressed in analyzed neural tubes (ISH in Fig. 4C) was used 
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as positive control of H3K27me3 ChIP. Fig. 4C shows that Noggin promoter, which is 
transcriptionally inactive in most of the neural tube cells, is enriched in H3K27me3 
nucleosomes (7.2±2.5 % of input), although this enrichment is smaller than in the 
NeuroD promoter (22.1±7.5 % of input). As expected, Hes5 promoter H3K27me3 
levels are in the same range of mock ChIP (Fig. 4C).  
Next, GFP+ cells from neural tubes electroporated in ovo with empty vector or with 
EZH2DSET were sorted by FACS and H3K27me3 levels at Noggin, NeuroD and Hes5 
promoters were analyzed by ChIP assays. Results in Fig. 4D show that, after 
EZH2DSET expression, H3K27me3 levels decrease at both, Noggin promoter (2.8±1.2 
fold) and NeuroD promoter (2.1±0.01 fold), though only Noggin is activated (Fig. 4B). 
Many promoters of key development regulators bear, in addition to H3K27me3, the 
active H3K4me mark (Bernstein et al., 2006; Mikkelsen et al., 2007; Pan et al., 2007; 
Zhao et al., 2007). It has been hypothesized that these marks’ combination creates a 
poised state suitable for rapid induction (Bernstein et al., 2006). To find whether the 
presence of H3K4me together with H3K27me3 contributes to gene expression 
regulation, we tested the presence of this histone modification at the three gene 
promoters analyzed previously. Fig. 4C shows that in HH16-18 embryo neural tube 
cells, Hes5, Noggin and NeuroD promoters are enriched in H3K4me2 (Fig. 4C; 
14.8±1.3, 6.±2.7, 3.1±1.5 % of input respectively). H3K4me2 levels at Noggin 
promoter are similar to H3K27me3 ones, while at NeuroD promoter H3K4me2 levels 
are clearly lower than H3K27me3 levels (Fig. 4C right diagram). ChIP assays analyzed 
by qPCR show that H3K4me2 is not affected by EZH2DSET over-expression (Fig. 4D). 
However, loss of H3K27me3 levels at Noggin promoter, leads to a predominance of 
H3K4me2 over H3K27me3. The contrary happens at NeuroD promoter where 
H3K27me3 is maintained above H3K4me2 levels even after the H3K27me3 reduction 
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by EZH2DSET over-expression. These ratios correlate well with Noggin and NeuroD 
expression levels observed after H3K27me3 reduction (Fig. 4D right diagram).  
 
Noggin transcription is regulated by BMP pathway 
Then, we asked whether Noggin upregulation upon a signal induction requires 
H3K27me3 removal. To establish the activity responsible for Noggin regulation, BMP, 
Wnt and Shh signaling pathways were activated and Noggin mRNA levels were 
determined by qPCR and  ISH. Results in Fig. 5A show a clear Noggin induction 24h 
after BMP electroporation (20.19±7.6-fold BMP7; 44.0±7.6-fold BMP4). A 7.1±1.2 
fold increase of Noggin expression is already observed 6h after BMP electroporation 
(Supplementary Fig. 5A). In addition, electroporation of constitutively active Smad1 
(one of the  BMP pathway effectors) also induces Noggin expression (Supplementary 
Fig. 5B). Next, we analyzed whether this activation is associated with changes in 
H3K27me3 at Noggin promoter. To do this, HH10 neural tubes electroporated in ovo 
with BMP were dissected out 24h-PE and analyzed by ChIP assays. Fig. 5B shows that 
BMP induced Noggin activation correlates with 3.3±2 fold decrease of H3K27me3 and 
a 1.6±0.003 fold increase of H3K4me2. Consequently, the resulting 
H3K4me2/H3K27me3 relative levels at Noggin promoter reach those observed at 
transcriptionally active Hes5 promoter (Fig. 5B right panel). Furthermore, H3K4me3, a 
histone modification associated to transcriptionally activated genes (Barski et al., 2007), 
increases 2.11±0.33 fold close to transcriptional start site of Noggin after BMP 
induction (Supplementary Fig. 6). Together, these data suggest that active H3K27me3 
demethylation of Noggin promoter takes place upon BMP signaling activation. JMJD3 
has been described as an H3K27me3 specific demethylase. Moreover, it has been 
suggested that JMJD3 activity could be associated to an H3K4 methyltransferase 
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activity (Lim et al., 2009). Therefore, we wondered whether JMJD3 histone 
demethylase (HDM) activity is involved in BMP-dependent Noggin induction. To 
answer this question, neural tubes were electroporated with BMP together with an 
empty vector or a dominant negative form of JMJD3 (JMJD3DN) that lacks HDM 
activity. Electroporated neural tube cells were separated by FACS to next analyze 
Noggin mRNA and promoter H3K27me3 levels. Fig. 5C shows that Noggin mRNA 
level is 1.7±0.2 fold lower when JMJD3DN is overexpressed correlating with 1.8±0.2 
higher H3K27me3 level at Noggin promoter. These results suggest that JMJD3 
contributes to BMP-induced Noggin expression. Then, we tested if JMJD3 interacts to 
Noggin promoter upon BMP pathway activation. To that end, neural tubes were 
electroporated with an empty vector, myc-JMJD3 or myc-JMJD3 with BMP. 
Electroporated neural tube cells were separated by FACS and the presence of JMJD3 at 
Noggin promoter was analyzed by ChIP assays, using myc antibody. Results show 
1.7±0.035 fold higher JMJD3 recruitment to Noggin promoter upon BMP signaling 
activation (Fig. 5C). On the other hand, immunoprecipitated chromatin levels are 
similar for myc-JMJD3 alone and for the empty vector electroporated neural tube cells. 
This indicates that in the absence of BMP hyperactivation (when Noggin is repressed in 
most of the neural tube cells) JMJD3 is not recruited to Noggin promoter. In agreement 
with this result, JMJD3 over-expression, which effectively reduces global H3K27me3 
levels (Supplementary Fig. 7A), has no significant effect on Noggin expression 
(Supplementary Fig. 7B), nor on H3K27me3 levels at the Noggin promoter 
(Supplementary Fig. 7C). All together, these data suggest that BMP pathway activates 
Noggin promoter through JMJD3-mediated H3K27 demethylation.  
Then, we sought to determine whether a direct link exists between BMP 
signaling pathway effectors and JMJD3. Smad1 is a BMP pathway effector (Liu and 
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Niswander, 2005). Upon BMP signaling activation Smad1 is phosphorylated and 
interacts with Smad4 to enter into the nucleus. Once in the nucleus, Smad1/Smad4 
heterodimer regulates its target genes interacting with co-activator or co-repressor 
proteins (Liu and Niswander, 2005). Fast BMP-induced Noggin expression 
(Supplementary Fig. 5A) and evidences of conserved Smad response-element presence 
at Noggin promoter (Supplementary Fig. 5C) suggest that Noggin could be a direct 
target of Smad1/Smad4. To test this hypothesis, HH10 neural tubes electroporated with 
BMP were dissected out 24h-PE and analyzed by ChIP using pSmad1/5/8 antibody. Fig. 
6A shows that BMP-induced Noggin activation correlates with endogenous phospho-
Smad1 recruitment (2.3±0.3 fold increase) to Noggin promoter. The observed effects of 
JMJD3 on BMP-induced Noggin expression (Fig. 5C) as well as the association of 
active Smad1 (Fig. 6A) and JMJD3 (Fig. 5C) at Noggin promoter upon BMP pathway 
activation led us to test whether Smad1/Smad4 interacts with JMJD3. CoIP experiments 
indicate that JMJD3 interacts with Smad1/Smad4 complex (Fig. 6B,C,D). Fig. 6B 
shows that Smad1 interacts with JMJD3 only in the presence of Smad4. Smad4 binding 
to JMJD3 also requires the presence of Smad1 (Fig. 6C). Moreover, Smad1/Smad4-
JMJD3 interaction increases after BMP pathway activation (Fig. 6D). All these data 
suggest that upon BMP pathway activation, Smad1/Smad4 heterodimer recruits JMJD3 
histone demethylase to Noggin promoter. This targeting results in a decrease of 
H3K27me3 levels that correlates with gene transcription activation. 
Finally, we sought to analyze whether BMP-dependent upregulation of Noggin 
plays any role controlling BMP activity. To do that, HH10 neural tubes were 
electroporated  with BMP and shRNA for Noggin (that partially reduces BMP-induced 
Noggin expression, Supplementary Fig. 8A) or BMP and shRNA control. They were 
dissected out 24h-PE and electroporated cells (GFP+) were separated by FACS for 
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mRNA extraction. Then we tested whether the reduction of Noggin levels affect BMP 
activity by analyzing mRNA levels of Id3 [a well known BMP transcriptional target 
(Hollnagel et al., 1999)] by qPCR and ISH. Fig. 7A shows that coelectroporation of 
BMP and Noggin shRNA leads to a 2.2±1.1 fold higher Id3 mRNA levels compared to 
BMP and shRNA control electroporation. Similar results were observed for Id1 
(Supplementary Fig. 8B). Moreover, Noggin over-expression leads to a reduction of 
Lhx2/9 and Isl1 dorsal interneurons, regulated by endogenous BMP pathway activity 
(Supplementary Fig. 8C). All together, these data strongly suggest that BMP-induced 
Noggin activation modulates BMP activity in the neural tube. 
 
DISCUSSION 
  Our studies have uncovered new insights into the in vivo role of H3K27me3 
mark in the context of lineage establishment within a tissue. We have shown that this 
epigenetic mark regulates dorsal patterning in developing neural tube by repressing 
Noggin promoter. BMPs are needed for the formation of dorsal neural cell types (Liu 
and Niswander, 2005). Thus, regulation of BMP activity by expression of BMP 
inhibitors plays an important role in this process. Our studies suggest a model in which 
Noggin, a known BMP antagonist, is regulated by an H3K27me3-dependent mechanism 
in the developing spinal cord (Fig. 7B). Noggin, is repressed in most of the developing 
neural tube cells. This repression requires H3K27me3 at Noggin promoter (1). In 
response to high BMP activity, Smad1/Smad4 and JMJD3 are recruited to Noggin 
promoter that in turn demethylates this promoter (2). H3K27me3 decrease, together 
with H3K4me increase, leads to Noggin full induction (3), which in turn rapidly 
moderates high BMP activity (4). This may occur in the most caudal developing spinal 
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cord, in which Noggin is expressed at dorsal cells to finally fine-tune levels of BMP 
activity along the anterior-posterior axis of the neural tube (Fig. 7B). 
 Interestingly, EZH2 and JMJD3 expression is higher at dorsal cells at the 
analyzed stages of neural tube development. This coincides with both high BMP (Sela-
Donenfeld and Kalcheim, 2002) and dorsal Noggin expression (Fig. 7B) in the 
developing neural tube. These observations support the role of H3K27me3 in the BMP-
dependent generation of dorsal neural subtypes described in our study. On the other 
hand, both EZH2 and JMJD3 are expressed in the VZ of the neural tube, and their 
mRNA levels are reduced in the MZ occupied by differentiated neurons. The loss of 
EZH2 expression during differentiation is a common feature, as it has been described in 
in vitro neural differentiation models (Sher et al., 2008) or during epidermal 
development (Ezhkova et al., 2009). Nonetheless it does not explain the observed global 
H3K27me3 increase during neural differentiation. These data suggest that in addition to 
EZH2 and JMJD3, other enzymes might be responsible for global H3K27me3 in the 
developing neural tube. According to this, high global H3K27me3 levels found in 
differentiated neurons could be maintained by observed high EZH1 expression at 
differentiated neurons. This correlates with the data supporting that EZH1 is the main 
responsible for HMT activity in differentiated tissues (Margueron et al., 2009).  
In agreement with the proposed role for H3K27me3 in development, our studies 
have uncovered a distinct promoter behavior in response to H3K27me3 removal that 
might be critical to determine the promoter activity in response to the developmental 
decisions. Our data show that some H3K27me3 target genes are not activated after 
H3K27me3 removal (as Neuro D). This observation suggests a context-dependent 
H3K27me3 function that might rely on the targeting of sequence-specific transcription 
factors in response to different pathway activation. H3K27me3 mark might ensure that 
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further developmental decisions are firmly controlled by robust induction signals. In 
agreement with this, different Polycomb and H3K27me3 targets have been identified in 
transformed human cells (Bracken et al., 2006; Squazzo et al., 2006), undifferentiated 
stem cells (Pasini et al., 2007) and human T cells (Barski et al., 2007; Roh et al., 2006) 
in which different signaling pathways operate.  
Another possibility to explain the lack of transcriptional consequences after 
EZH2DSET over-expression implies the chromatin context of H3K27me3 target genes. 
The fact that Noggin, but not NeuroD, is activated after H3K27me3 removal, even in 
the absence of any induction signal, suggest that the presence of H3K27me3 should be 
combined with other chromatin features to fine tune the transcriptional regulation. In 
ESCs H3K4me active and H3K27me3 repressive marks coexist over many of the 
lineage-regulatory genes that are governed by PRCs (Haudenschild et al., 2004; Liu and 
Niswander, 2005; Pasini et al., 2007). They are found in transcriptionally silenced genes 
and they poise them for activation upon a signal induction (Bernstein et al., 2006). 
Transcriptional activation of these genes requires an increase on H3K4me over 
H3K27me3 levels. Our results show that both, Noggin and NeuroD promoters contain 
active and repressive marks. However only Noggin is activated after H3K27me3 
reduction. The ratio between H3K4me2 and H3K27me3 at Noggin promoter is higher 
than at NeuroD promoter, suggesting this ratio (and not only the presence of both 
marks) might be determinant in the genes becoming active or repressed at some 
particular development stage. Therefore our data suggest that H3K27me3/H3K4me2 
relative levels might regulate the promoter sensitivity to respond to developmental 
decisions. 
We have shown that small changes in Noggin expression, mediated by discreet 
changes in H3K27me3 levels of its promoter, lead to altered BMP-regulated dorsal 
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patterning in the neural tube. Many processes of neural development, like neural 
induction and axon guidance, are also regulated by BMP signaling (Liu and Niswander, 
2005). These processes are temporally and spatially separated along the nervous system 
development. Thus, the duration and strength of BMP signaling are essential to correct 
neural development. One way to modulate BMP activity is by the transcriptional 
activation of its own extracellular antagonists (Haudenschild et al., 2004; Liu and 
Niswander, 2005). Here we also show that Noggin expression is upregulated fast after 
BMP over-expression. This upregulation is essential to moderate BMP activity, since 
the partial blocking of BMP-mediated Noggin induction, increases transcriptional 
activity of Id1 and Id3 BMP target genes (Hollnagel et al., 1999). Moreover, we 
demonstrated that Noggin expression is directly regulated by BMP responding Smad 
proteins (Smad1/5/8). BMP-induced Noggin expression is accompanied by a JMJD3-
dependent removal of H3K27me3 from Noggin promoter. The identified JMJD3 
interaction with Smad1/Smad4 heterodimer, suggests that they could form a complex 
responsible for JMJD3 recruitment to Noggin promoter. One question that remains to be 
answered is whether this mechanism is also working for other BMP target genes. 
Our study has uncovered a fine-tuning regulatory mechanism of the BMP 
pathway where chromatin structure is implicated. We propose that the chromatin 
structure at Noggin promoter allows a fast response to small BMP activity variations, 
thus ensuring the proper BMP levels required for nervous system development. A key 
question is whether this is a developmental-stage specific mechanism that only operates 
during embryonic development or it can be a more general mechanism. The latter is 
supported by data showing that both EZH2 and BMPs are implicated in the 
development of several cancers (Haudenschild et al., 2004; Varambally et al., 2002). 
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However, further evidence will be required to ascertain the contribution of H3K27me3-
mediated BMP regulation in tumorigenesis. 
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FIGURE LEGENDS 
Figure 1. H3K27me3 global levels increase during neural differentiation 
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(A) Diagram showing regions occupied by proliferating progenitors (ventricular zone, 
VZ) and post-mitotic neurons (mantle zone, MZ) in HH25 and HH14 (only progenitors) 
chick embryo spinal cord. TZ: transition zone. (B) H3K27me3 levels of HH14 and 
HH25 embryo spinal cord histone extracts determined by immunoblotting. 
(C) Sections from HH25 chick embryos (brachial region) stained with anti-H3K27me3  
and DAPI (DNA). The graphic underneath shows mean of H3K27me3/DAPI (DNA) 
signal intensity in individual cells relative to progenitor mean intensity. Intensities were 
quantified by Leica LAS-AF software. Data show mean of n=80 cells (from 4 different 
embryo sections). Error bars indicate s.d. ***p<0.0001  
(D) EZH2 and (E) JMJD3 mRNA analyzed by HH10, 14 and 25 chick embryos ISH. 
 
Figure 2. H3K27me3 maintenance is not essential for neural differentiation or for 
progenitor proliferation 
HH10 embryos were electroporated with EZH2DSET, EZH2 or the empty vector in a 
bicistronic vector containing GFP. 
(A) H3K27me3 immunostaining (grey and red) of 24h post-electroporated (24h-PE) 
embryos. The graphic shows mean of H3K27me3 signal intensity in EZH2DSET 
electroporated individual cells (GFP+, green bar), relative to non-electroporated ones 
(grey bar). Intensities were quantified by Leica LAS-AF software. Data show mean of 
n=44 cells (from 4 different electroporated embryo sections). Error bars indicate s.d. 
***p<0.0001. 
(B) TUJ immunostaining (grey and red) of 48h-PE embryos.  
(C) BrdU immunostaining (grey and red) of 24h-PE embryos. The graphic shows 
percentage of electroporated cells (GFP+) positive for BrdU. Data show mean of n=30 
sections (from 4-6 embryos). Error bars indicate s.d. 
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Figure 3. H3K27me3 regulates BMP activity  
(A) LHX2/9 (upper panel) or ISL1/2 (lower panel) immunostaining 48h-PE of 
EZH2DSET, EZH2 or  empty vector in HH16 chick embryos. Graphics show 
quantification of LHX2/9+ (upper) and dorsal ISL1/2+ (lower) cells on electroporated 
(GFP+) versus non-electroporated side. Data show mean of n=30-35 sections (from 4-6 
embryos). Error bars indicate s.d. *p<0.05; ***p<0.0001. 
 (B) Pax6 and Pax7 immunostaining 24h-PE of BMP7, BMP7 and EZH2DSET or 
BMP7 and EZH2 in HH10 chick embryos. 
 
Figure 4. Noggin expression is regulated by H3K27me3 
(A) Diagram summarizing experimental procedure before microarray analysis. HH10 
embryos were electroporated with the empty vector or EZH2DSET (bicistronic vector 
containing GFP). 24h-PE (HH16-18) neural tubes were dissected out and GFP+ cells 
were sorted by FACS. mRNA was extracted and retro-transcribed for microarray 
analysis (right) or qPCR (B). List of genes upregulated in EZH2DSET and found in GO 
terms relating to nervous system development (right).  
(B) Noggin, Hes5 and NeuroD mRNA relative levels determined by qPCR.  
(C) Hes5, Noggin and NeuroD mRNA in situ hybridization in HH16-18 embryo spinal 
cord (upper). ChIP assays using HH16-18 chick neural tubes were performed using anti-
H3K27me3 and H3K4me2 antibodies; and their levels at Hes5, Noggin and NeuroD 
promoters (-2000bp from TSS) were analyzed by qPCR (lower graphs). Right graph 
represents the H3K27me3 occupancy relative to H3K4me2 occupancy in each promoter 
and the mRNA expression level of each gene in WT HH16-18 spinal cord. Relative 
occupancy was determined calculating the percentage of each histone mark related to 
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the number resulting from the addition of both histone mark levels (% input). (D) 
Diagram summarizing the experimental procedure to obtain cells for ChIP (upper). 
HH10 chick neural tubes were electroporated with the empty vector or EZH2DSET. 
24h-PE (HH16-18) neural tubes were dissected out and GFP+ electroporated cells were 
sorted by FACS for ChIP assays. Lower graphs show H3K27me3 and H3K4me2 levels 
at Hes5, Noggin and NeuroD promoters (-2000bp from TSS) analyzed by qPCR. Right 
graph represents the H3K27me3 occupancy relative to H3K4me2 occupancy in each 
promoter and the mRNA expression level of each gene in EZH2DSET electroporated 
spinal cord cells. Relative occupancy was estimated as in (C) but using data resulting 
from the difference between each histone mark level in empty vector and EZH2DSET 
normalized to the WT levels. (A-D) Results are mean of two independent experiments. 
Error bars indicate s.d. 
 
Figure 5. BMP pathway regulates Noggin transcription via H3K27 demethylation 
HH10 embryos were electroporated and neural tubes were dissected out 24h-PE (A-B).  
(A) Relative Noggin mRNA levels quantified by qPCR (top panel) and ISH (bottom 
panel) after electroporation with BMP7, BMP4, Wnt, Shh or empty vector.  
(B) ChIP assays were performed as in Fig. 4C using BMP4 electroporated neural tubes. 
Graphs show H3K27me3 and H3K4me2 levels at Hes5, Noggin and NeuroD promoters 
(-2000bp from TSS) analyzed by qPCR. Right graph represents the H3K27me3 
occupancy relative to H3K4me2 occupancy in each promoter and the mRNA expression 
level of each gene after BMP4 electroporation. Relative occupancy was estimated as in 
(Fig. 4C) but using data resulting from the difference between each histone mark level 
in empty vector and BMP4 normalized to the WT levels. (C) HH10 embryos were 
electroporated and 24h-PE neural tubes were dissected out for GFP+ cell sorting. 
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Graphs show Noggin mRNA relative levels (left) and H3K27me3 levels at Noggin 
promoter (-2000bp from TSS) (middle) in empty vector and BMP4 or JMJD3DN and 
BMP4 electroporated neural tube cells. Right graph shows JMJD3 levels at Noggin 
promoter (-2000bp from TSS) in empty vector, myc-JMJD3 or myc-JMJD3 and BMP4 
electroporated neural tube cells. JMJD3 levels were analyzed by qPCR of DNA purified 
from ChIP with anti-Myc antibody (Abcam). (A-C) Results are mean of two 
independent experiments. Error bars indicate s.d. 
 
Figure 6. BMP induces pSmad1 recruitment to Noggin promoter and the 
interaction of Smad1/Smad4 complexes with JMJD3 
(A) HH10 neural tubes were electroporated with empty vector or BMP4 and dissected 
out 24h-PE. The presence of endogenous phospho-Smad1 (pSmad1) at Noggin 
promoter (-1000bp from TSS) analyzed by qPCR of purified DNA from ChIP.Results 
are mean of two independent experiments. Error bars indicate s.d. 
(B, C, D) Immunoblot of CoIP experiments. Top panel indicates the transfected plasmid 
combination used in each line. CoIPs were performed using the anti-Myc antibody. (B) 
Smad1 and JMJD3 interaction in the absence or presence of Smad4. (C) Smad4 
interacts with JMJD3 in presence of Smad1. (D) Smad1/Smad4 and JMJD3 interaction 
in the absence or presence of BMP4. IB (immunoblot); IP (immunoprecipitation). 
Results are representative of two independent experiments. 
 
Figure 7. BMP-dependent upregulation of Noggin plays a role controlling BMP 
activity 
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(A) Id3 mRNA levels determined by qPCR of FACS separated GFP+ cells or ISH of 
24h-PE dissected out embryos electroporated at HH10 with indicated plasmids. Results 
are mean of two independent experiments. Error bars indicate s.d. 
(B) Model for Noggin regulation by H3K27me3 in developing spinal cord (see text for 
details).  







